Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

A new method accurately measures clobetasol propionate in hair and skin.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

A balanced, personalized approach combining lifestyle changes and therapies is essential for managing PCOS effectively.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib is not very effective for severe alopecia areata.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Sonidegib and vismodegib have different side effects and reporting patterns.

Baricitinib was effective in treating alopecia areata in two major trials.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Lower SHBG levels may increase the risk of PCOS.

Baricitinib can cause excessive hair growth.

Scalp cooling helps prevent hair loss during certain breast cancer treatments, especially when anthracyclines aren't used.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Early diagnosis and personalized treatment of PCOS improve quality of life and prevent complications.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.